The AMA Commission to End Health Care Disparities asked the DRA Project to develop a paper that identifies future opportunities in the emerging area of biomonitoring to reduce disparities. The paper, based on the findings and recommendations of the DRA Project's biomonitoring component, funded by the Robert Wood Johnson Foundation, reviews developments in testing platforms, applications in diabetes and cancer, key opportunities, caveats (e.g. understanding the limited role of biomonitoring), criteria for biomonitoring applications, and provides recommendations. Click here to read it.





